Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-00592379 for Erectile Dysfunction
NCT00273416Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of PF-000592379 in erectile dysfunction (ED) (4 arms), sponsored by Pfizer. Primary endpoint: Duration of penile erections of greater than or equal to 60% rigidity. Started Jan 2006; status: completed.
02
Drugs
PF-000592379
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00273416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00273416.